Pancreatic Cancer Research

ResearcherUniversity of PisaActive in the last 2 years

Niccolò Napoli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2538-9158; OpenAlex author ID A5088548992. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
61
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 4 papers

Papers 17

  1. Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
  2. Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3↗
  3. Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including ar… Co-author DOI 10.1093/bjsopen/zrag058↗
  4. ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18479-z↗
  5. Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18212-w↗
  6. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. Co-author DOI 10.1007/s13304-024-01860-0↗
  7. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
  8. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas. Co-author DOI 10.1007/s13304-023-01587-4↗
  9. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
  10. Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection. Co-author DOI 10.1007/s13304-020-00883-7↗
  11. Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications. Co-author DOI 10.3389/fonc.2020.00064↗
  12. A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status. First author DOI 10.1007/s00464-018-6301-2↗
  13. Corrigendum to "Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancrea… Co-author DOI 10.1016/j.ijsu.2019.05.015↗
  14. Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Coh… Co-author DOI 10.3390/cancers11070939↗
  15. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral uni… Co-author DOI 10.1016/j.ijsu.2018.05.025↗
  16. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. Co-author DOI 10.1186/s12893-017-0311-1↗
  17. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients. Co-author DOI 10.1245/s10434-016-5123-5↗

Closest collaborators

The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ugo Boggi · 12 shared papers, 2016–2026 · strength 1.43
  2. Emanuele F. Kauffmann · 7 shared papers, 2019–2026 · strength 0.98
  3. Marc G. Besselink · 3 shared papers, 2025–2026 · strength 0.59
  4. Daniela Campani · 5 shared papers, 2019–2023 · strength 0.57
  5. Allegra Ripolli · 2 shared papers, 2025–2026 · strength 0.41
  6. Kongyuan Wei · 2 shared papers, 2025–2026 · strength 0.41
  7. Riccardo Casadei · 2 shared papers, 2025–2026 · strength 0.41
  8. Sergio Alfieri · 2 shared papers, 2025–2026 · strength 0.41
  9. V. Egorov · 2 shared papers, 2025–2026 · strength 0.41
  10. Gregory G. Tsiotos · 2 shared papers, 2025–2026 · strength 0.41
  11. Alessandro Zerbi · 2 shared papers, 2025–2026 · strength 0.41
  12. Yuichi Nagakawa · 2 shared papers, 2025–2026 · strength 0.41
  13. Benedetto Ielpo · 2 shared papers, 2025–2026 · strength 0.41
  14. Elena B. Rangelova · 2 shared papers, 2025–2026 · strength 0.41
  15. Emilio Vicente · 2 shared papers, 2025–2026 · strength 0.41
  16. Giuseppe Fusai · 2 shared papers, 2025–2026 · strength 0.41
  17. Roberto Coppola · 2 shared papers, 2025–2026 · strength 0.41
  18. Andrea Cacciato Insilla · 4 shared papers, 2019–2021 · strength 0.38
  19. Caterina Vivaldi · 3 shared papers, 2019–2021 · strength 0.30
  20. Enrico Vasile · 3 shared papers, 2019–2021 · strength 0.30
  21. Elio Jovine · 4 shared papers, 2016–2019 · strength 0.26
  22. Niccolò Petrucciani · 4 shared papers, 2016–2019 · strength 0.26
  23. Giuseppe R. Nigri · 4 shared papers, 2016–2019 · strength 0.26
  24. Francesco Minni · 4 shared papers, 2016–2019 · strength 0.26
  25. Giovanni Ramacciato · 4 shared papers, 2016–2019 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.